Weekly Recap | GENSCRIPT BIO -8.92%, pullback outpacing the Hang Seng IndexWeekly Review·Nov 21, 2026 at 05:13 AM01548-7.96%
AIâs billions and slick pledges heap pressure on pharma veteransBusinesstimes News·Nov 20, 2026 at 11:58 AMABBV+0.94%MRK+0.69%
Weekly Recap | GENSCRIPT BIO -3%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:08 AM01548-7.96%
JPM: GENSCRIPT BIO US New Nucleic Acid Screening Rules a Manageable IssueAASTOCKS News·Nov 10, 2026 at 06:00 AM01548-7.96%
M Stanley: China AI Drug R&D Financing Accelerates, GENSCRIPT BIO Benefits from Wet Lab DemandAASTOCKS News·Nov 9, 2026 at 09:20 AM01548-7.96%
Weekly Recap | GENSCRIPT BIO -15.04%, consensus target above spotWeekly Review·Nov 7, 2026 at 05:33 AM01548-7.96%